VIETNAM AND MYANMAR: Spotlight on Pharmaceutical Experience

With the award of several pharmaceutical manufacturing facilities within the last 2 years, Archetype Group has established itself as a key player in this very specialist industrial sector.

Sanofi Aventis, already with two factories close to saturation in HCMC, commissioned Archetype for Design, Project/construction Management and Cost Management of a new 35,000m2 factory at Saigon Hi-Tech Park. With approximately 625 rooms, including 48 air handling units, the facility produces pharmaceuticals in pill and syrup forms.

Medochemie is a pharmaceutical firm headquartered in Cyprus and a producer of generic products. The company recently broke ground on their new 10,000m2 facility in Binh Duong, in which Archetype is the turnkey consultant responsible for Engineering, Project/construction Management and Cost Management.

Also located in Binh Duong is a new 12,000m2 factory for Nippon Chemiphar from Japan. Archetype has been providing Design Review, Project Management, Construction Supervision and Quantity Surveying services and will need to make sure that it is Europe & Japan GMP compliant.

Finally, we have been awarded Project Management for STADA’s new 16,000m2 plant in Myanmar. STADA is a German company and one of the first western pharmaceutical companies to commence manufacturing in Myanmar. This project is also the first in this sector for Archetype in the country.

Source Archetype Group